All core curriculum post-test modules are free for attendees until midnight EDT on Sunday, July 31.
Stay on top of your Maintenance of Certification (MOC) while at the ATS 2016 International Conference.
Earn 31 American Board of Internal Medicine MOC Medical Knowledge Points by participating in the Adult Core Curriculum sessions for all three pillars—pulmonary, critical care, and sleep. Earn 10 American Board of Pediatrics MOC Part 2 Self-Assessment credits by participating in the Pediatric Core Curriculum.
Pre-Test Information
Click the following to access the pre-test (beginning Friday, May 6).
Prepare for the MOC by picking up an MOC Study Guide. The study guide includes exam questions and will be available on a first-come, first-served basis in the core session rooms and the ATS Center. The guide cannot be submitted for credit.
To earn credit, participants must complete a post-test online. Post-tests will be available as follows:
- Monday, May 16: Pulmonary, beginning at 5 p.m. (PDT)
- Tuesday, May 17: Sleep, beginning at 5 p.m. (PDT)
- Wednesday, May 18: Pediatrics, beginning at 8 a.m. (PDT)
- Thursday, May 18: Critical Care, beginning at 4 p.m. (PDT)
All core curriculum post-test modules are free for attendees until midnight EDT on Sunday, July 31.
The ABIM and ABP require internists and subspecialists who were certified during or after 1990 to continually participate in MOC program activities. In January 2014, ABIM modified its MOC program. Physicians also must earn 100 MOC points every five years to maintain their certifications, and they must earn some points in an MOC activity every two years to meet the new requirements. The ABP had previously implemented similar requirements and timing for pediatric subspecialists.
The guide cannot be submitted for credit.
For questions, email moc@thoracic.org.
Pulmonary Clinical Core Curriculum I is supported by educational grants from AstraZeneca LP and GlaxoSmithKline.
Pulmonary Clinical Core Curriculum II is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech.